From Military.com:
“Over-the-Counter
Home Test for COVID-19 Gets US Green Light”
The first home
test for COVID-19 that doesn't require a prescription will soon be on U.S.
store shelves
U.S. regulators
Tuesday authorized the rapid coronavirus test, which can be done entirely at
home. The announcement by the Food and Drug Administration represents another
important — though incremental — step in efforts to expand testing options. Regulators
granted emergency use for a similar home test last month, but that one needs a
doctor’s prescription.
The agency's
action Tuesday allows sales in places like drugstores "where a patient can
buy it, swab their nose, run the test and find out their results in as little
as 20 minutes,” said FDA Commissioner Stephen Hahn, in a statement. Initial
supplies of the over-the-counter test will be limited. Australian manufacturer
Ellume said it expects to produce 3 million tests next month before ramping up
production over the first half of 2021. A company spokesperson said the test
will be priced around $30 and be available at pharmacies and for purchase
online. The kit includes a nasal swab, a chemical solution and a testing strip.
The test connects digitally to a smart phone app that displays the results and
then helps interpret them. Users can also connect with a health professional
via the app.
For months,
health experts have stressed the need for fast, widespread home testing so that
people can screen themselves and avoid contact with others if they have an
infection. But the vast majority of tests still require a nasal swab performed
by a health worker that must be processed at high-tech laboratories. That
typically means waiting days for the results. About 25 tests allow people to
collect their own sample at home— a nasal swab or saliva — but then that's
shipped to a lab. Ellume’s test looks for viral proteins shed by COVID-19,
which is different from the gold standard tests that look for the genetic
material of the virus. Like other tests that scan for proteins, FDA officials
noted that Ellume’s test can deliver a small percentage of false positive and
false negative results. People who get a negative result but have coronavirus
symptoms should follow up with a health professional, the agency said.
Currently the
U.S. is testing nearly 2 million people daily. Most health experts agree the
country needs to be testing many times more and researchers at Harvard have
pushed for cheap, paper home tests. Still, Dr. Michael Mina of Harvard called
the new test “a great addition," to existing options, though he cautioned
that its price could limit access. “This is a milestone, with reservations,”
Mina said in an email. “I just hope it doesn’t drive more of a wedge between
haves and have nots." For people with insurance, federal law requires that
plans cover the cost of COVID-19 testing.
^ This test
will give a lot of people more control over their own lives and hopefully will
allow for things to return to normal soon. ^
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.